Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Complement C3 inhibitory peptide AMY-101 ameliorates brain injury in a mouse model of NMOSD.
"Find sunshine wherever you can": A conceptual model of psychosocial wellness based on perspectives from individuals with multiple sclerosis.
CAR T cell therapy beyond cancer: current status, challenges and future prospects.
Redox Molecules in Aging and Neurodegenerative Disorders.
PARP inhibition attenuates neuroinflammation and demyelination in a rat model of multiple sclerosis: A longitudinal [C]PBR28 TSPO PET imaging study.
Correction: Utility of Multi‑Analyte Protein Assay to Distinguish Multiple Sclerosis Clinical Relapse from Pseudoexacerbation.
The Effect of Acupressure on Beta-Endorphin, Hypocretin, Cognition, and Patient-Reported Outcome Measures in Multiple Sclerosis Patients.
Late Infective Endocarditis Involving a Gore HELEX® Atrial Septal Occluder Presenting as a Multiple Sclerosis Pseudo-Flare: A Case Report.
Altered T1w/T2w-FLAIR Ratio in White Matter Hyperintensities as an Indicator of Structural Integrity Loss: Association with Alzheimer's Disease and Vascular Dementia.
Microvascular remodeling and endothelial dysfunction across the post-COVID-19 spectrum: a prospective observational case-control study.
Baseline F-FDG PET/CT-derived heterogeneity index predicts poor pathological response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Pathobiology-guided diagnostic advances, biomarker discovery, and emerging therapeutic strategies in progressive multiple sclerosis.
Taking another look: LBSL diagnosed in adulthood masquerading as multiple sclerosis.
Beyond Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Anti-Contactin-1 Autoimmune Nodopathy Unmasked by Proteinuria.
Can Spasticity Be Prevented? Insights from Preclinical and Clinical Evidence.
Beyond PAD Inhibition: Emerging Avenues and Natural Products for Targeting Citrullination in Immune Diseases.
Treatment Preferences for Subcutaneous Immunoglobulin Among Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Caregivers, and Physicians: A Discrete Choice Experiment.
Multimodal machine learning for distinguishing pediatric multiple sclerosis from non-inflammatory conditions using optical coherence tomography.
Spinal Aneurysmal Bone Cyst in a Pregnant Patient Presenting with Neurological Symptoms: A Case Report.
Corrigendum to "Treatment discontinuation in older patients with multiple sclerosis" [Multiple Sclerosis and Related Disorders, Volume 103, November 2025, 106741].
Multiple sclerosis in Colombia: nationwide surveillance-based estimates and trends, 2016-2024.
[Recommendations for the diagnosis and treatment of optic neuromyelitis in children and adolescents].
Safety and Effectiveness of Inebilizumab in Patients with Neuromyelitis Optica Spectrum Disorder: Interim Analysis of a Post-marketing Surveillance in Japan.
Multimodal discovery of a pathogenic B cell-dependent T cell state in multiple sclerosis.
Immunoregulatory artificial lymph nodes restore antigen-specific tolerance in advanced multiple sclerosis.
Pages
« first
‹ previous
…
911
912
913
914
915
916
917
918
919
…
next ›
last »